Vectura Group plc:企業の戦略・SWOT・財務情報

◆英語タイトル:Vectura Group plc - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C1951
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Vectura Group plc – Strategy, SWOT and Corporate Finance Report
Summary

Vectura Group plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Vectura Group plc (Vectura or ‘the group’) is engaged in the development of pharmaceutical therapies for the treatment of airways-related diseases. It develops inhalation products to diseases such as obstructive pulmonary disease (COPD), cystic fibrosis, asthma, chronic pulmonary fibrosis and other diseases. It offers dry powder inhalers (DPIs), pressurized metered dose inhaler (pMDI) and smart nebulizer delivery systems. The group’s portfolio is comprised of partnered and licensed marketed products as well as branded and generic investigational drugs. The group operates in the US, the UK and other European countries. It is headquartered in Wiltshire, UK.

Scope

- Detailed information on Vectura Group plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Vectura Group plc in the form of a SWOT analysis
- An in-depth view of the business model of Vectura Group plc including a breakdown and examination of key business segments
- Intelligence on Vectura Group plc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Vectura Group plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Vectura Group plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Vectura Group plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Vectura Group plc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Vectura Group plc: Company Overview 9
Vectura Group plc: Overview and Key Facts 9
Vectura Group plc: Overview 9
Vectura Group plc: Key Facts 9
Vectura Group plc: Key Employees 10
Vectura Group plc: Key Employee Biographies 11
Vectura Group plc: Major Products and Services 15
Vectura Group plc: Company History 17
Vectura Group plc: Management Statement 21
Vectura Group plc: Locations and Subsidiaries 24
Vectura Group plc: Key Competitors 25
Vectura Group plc: Company Analysis 26
Vectura Group plc: Business Description 26
Vectura Group plc: SWOT Analysis 27
Vectura Group plc: SWOT Overview 27
Vectura Group plc: Strengths 27
Vectura Group plc: Weaknesses 28
Vectura Group plc: Opportunities 28
Vectura Group plc: Threats 29
Vectura Group plc: Corporate Financial Deals Activity 30
Vectura Group plc: Financial Deals Overview 30
Vectura Group plc: Targets and Partners 32
Vectura Group plc: Top Deals 2014 – 2018YTD* 33
Vectura Group plc: Advisors 34
Vectura Group plc: Top Legal Advisors 34
Vectura Group plc: Top Financial Advisors 34
Vectura Group plc: Mergers and Acquisitions 35
Vectura Group plc: Capital Raising 36
Vectura Group plc: Partnership 37
Vectura Group plc: Recent Developments 38
Vectura Group plc: News and Events Summary 38
Vectura Group plc: Business Expansion 41
Vectura Group plc: Corporate Governance 41
Vectura Group plc: Financial Deals 42
Vectura Group plc: Financial Performance 42
Vectura Group plc: Market Developments 43
Vectura Group plc: Research & Development 44
Vectura Group plc: Strategy and Operations 45
Appendix 46
Contact Us 46
Methodology 46
About MarketLine 47

List of Tables
Table 1: Vectura Group plc: Key Facts
Table 2: Vectura Group plc: Key Employees
Table 3: Vectura Group plc: Locations and Subsidiaries
Table 4: Vectura Group plc: Key Competitors
Table 5: Vectura Group plc: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Vectura Group plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Vectura Group plc: M&A Average Deal Size - Value (US$m)
Table 8: Vectura Group plc: Targets and Partners
Table 9: Vectura Group plc: Top Deals 2014 - 2018YTD*
Table 10: Vectura Group plc: Legal Advisor Ranking by Value (US$m)
Table 11: Vectura Group plc: Financial Advisor Ranking by Value (US$m)
Table 12: Vectura Group plc: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Vectura Group plc: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Vectura Group plc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 15: Vectura Group plc: Capital Raising by Deal Type (2014 - YTD*2018)
Table 16: Vectura Group plc: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 17: Vectura Group plc: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 18: Vectura Group plc: News and Events Summary
Table 19: Vectura Group plc: Business Expansion
Table 20: Vectura Group plc: Corporate Governance
Table 21: Vectura Group plc: Financial Deals
Table 22: Vectura Group plc: Financial Performance
Table 23: Vectura Group plc: Market Developments
Table 24: Vectura Group plc: Research & Development
Table 25: Vectura Group plc: Strategy and Operations

List of Figures
Figure 1: Vectura Group plc: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Vectura Group plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Vectura Group plc: M&A Average Deal Size - Value (US$m)
Figure 4: Vectura Group plc: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Vectura Group plc: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Vectura Group plc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 7: Vectura Group plc: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 8: Vectura Group plc: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 9: Vectura Group plc: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Vectura Group plc:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • VION N.V.:企業の戦略・SWOT・財務分析
    VION N.V. - Strategy, SWOT and Corporate Finance Report Summary VION N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Enterprise Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Enterprise Therapeutics Ltd (Enterprise Therapeutics) is a drug discovery company that offers research and development of novel therapies for the treatment of respiratory diseases. The company also identifies novel targets and compounds which reduces the mucus production. It provides therape …
  • Sharps Compliance Corp (SMED):企業の財務・戦略的SWOT分析
    Summary Sharps Compliance Corp (Sharps) is a healthcare waste solution company that offers regulatory compliant services. The company offers products such as sharps disposal systems, public sharps safety, takeaway medication recovery system, collection and disposal system, complete needle collection …
  • Asian Citrus Holdings Ltd (73):企業の財務・戦略的SWOT分析
    Asian Citrus Holdings Ltd (73) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Titan Medical Inc (TMD):医療機器:M&Aディール及び事業提携情報
    Summary Titan Medical Inc (Titan) is a development stage company that designs and develops a robotic surgical system for application in minimally invasive surgery (MIS). The company's lead product candidate, single port robotic (SPORT) surgical system is a single-incision robotic surgical system. It …
  • LifeAssay Diagnostics (Pty) Ltd:企業の製品パイプライン分析2018
    Summary LifeAssay Diagnostics (Pty) Ltd (LifeAssay) is a medical device manufacturer. The company offers urine analysis, urine adulteration tests, lifestyle tests, lateral flow tests and industrial tests. It manufactures non-invasive semi-quantitative dipstick tests intended to measure selective phy …
  • Brooks MacDonald Group PLC (BRK):企業の財務・戦略的SWOT分析
    Brooks MacDonald Group PLC (BRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Bank Dhofar SAOG:企業の戦略・SWOT・財務分析
    Bank Dhofar SAOG - Strategy, SWOT and Corporate Finance Report Summary Bank Dhofar SAOG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • QPS Austria GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary QPS Austria GmbH (QPS), a subsidiary of QPS Holdings LLC, is a contract research organization (CRO) which provides preclinical and clinical research services. The company offers in vivo services which include generating, characterizing and maintaining transgenic disease models and use them f …
  • Valero Energy Corp (VLO):石油・ガス:M&Aディール及び事業提携情報
    Summary Valero Energy Corp (Valero) is a downstream company that manufactures and markets transportation fuels and petrochemical products. The company’s assets include petroleum refineries, ethanol plants and renewable diesel production from a joint venture. Its refineries produce gasoline, diesel, …
  • Tokyu Corp:企業の戦略・SWOT・財務分析
    Tokyu Corp - Strategy, SWOT and Corporate Finance Report Summary Tokyu Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • JSFC Sistema (AFKS):企業の財務・戦略的SWOT分析
    JSFC Sistema (AFKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Galaxy Entertainment Group Ltd:企業の戦略・SWOT・財務分析
    Galaxy Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Galaxy Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Ossur hf (OSSR):企業の財務・戦略的SWOT分析
    Ossur hf (OSSR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Terumo BCT Inc:企業の戦略的SWOT分析
    Terumo BCT Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Citius Pharmaceuticals Inc (CTXR):企業の財務・戦略的SWOT分析
    Summary Citius Pharmaceuticals Inc (Citius), formerly Trail One Inc is a specialty pharmaceutical company that focuses on the development and commercialization of anti-infective products in adjunct cancer care, and critical care drug products. The company’s proprietary product candidates include Min …
  • Whirlpool Corporation (WHR):企業の財務・戦略的SWOT分析
    Whirlpool Corporation (WHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Oriental Food Industries Holdings Berhad:企業の戦略・SWOT・財務分析
    Oriental Food Industries Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary Oriental Food Industries Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Delcath Systems Inc (DCTH)-医療機器分野:企業M&A・提携分析
    Summary Delcath Systems Inc (Delcath) is a specialty pharmaceutical and medical device company, which specializes in developing percutaneous perfusion technologies to treat primary and metastatic liver cancers. Its patented drug delivery platform delivers ultra-high doses of anti-cancer drugs to the …
  • Bajaj Electricals Ltd. (BAJAJELEC):企業の財務・戦略的SWOT分析
    Bajaj Electricals Ltd. (BAJAJELEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆